What companies are BEAM's competitors?

Beam Therapeutics Inc. (BEAM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does BEAM compare to its peers?

The peer comparison table on this page shows Beam Therapeutics Inc. (BEAM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does BEAM operate in?

Beam Therapeutics Inc. (BEAM) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

BEAM

Beam Therapeutics Inc.

NASDAQ·Biotechnology · Healthcare

$23.79$0.26−1.08%

Pre-market·$24.02+0.97%

Market cap$2.46B·Market closed·Oct 26 4:00 PM EDT

Frequently Asked Questions About BEAM

What companies are BEAM's competitors?: Beam Therapeutics Inc. (BEAM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BEAM compare to its peers?: The peer comparison table on this page shows Beam Therapeutics Inc. (BEAM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BEAM operate in?: Beam Therapeutics Inc. (BEAM) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

BEAM

Beam Therapeutics Inc.

NASDAQ·Biotechnology · Healthcare

$23.79$0.26−1.08%

Pre-market·$24.02+0.97%

Market cap$2.46B·Market closed·Oct 26 4:00 PM EDT

Peers

Sort:


CRSPCRSPCRISPR Therapeutics AG	CRISPR Therapeutics AG	$49.22	$4.8B
NTLANTLAIntellia Therapeutics, Inc.	Intellia Therapeutics, Inc.	$11.26	$1.6B
ALLOALLOAllogene Therapeutics, Inc.	Allogene Therapeutics, Inc.	$1.21	$418.0M
EDITEDITEditas Medicine, Inc.	Editas Medicine, Inc.	$2.40	$368.6M
FATEFATEFate Therapeutics, Inc.	Fate Therapeutics, Inc.	$2.13	$248.3M
DTILDTILPrecision BioSciences, Inc.	Precision BioSciences, Inc.	$6.41	$176.9M
CLLSCLLSCellectis S.A.	Cellectis S.A.	$0.97	$97.4M
CRBUCRBUCaribou Biosciences, Inc.	Caribou Biosciences, Inc.	$0.53	$56.3M

Frequently Asked Questions About BEAM

What companies are BEAM's competitors?: Beam Therapeutics Inc. (BEAM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BEAM compare to its peers?: The peer comparison table on this page shows Beam Therapeutics Inc. (BEAM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BEAM operate in?: Beam Therapeutics Inc. (BEAM) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.